- Home
- BBCP vs DCTH Comparison
BBCP vs DCTH Comparison
Compare BBCP & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBCP
- DCTH
- Stock Information
- Founded
- BBCP 1983
- DCTH 1988
- Country
- BBCP United States
- DCTH United States
- Employees
- BBCP N/A
- DCTH N/A
- Industry
- BBCP Engineering & Construction
- DCTH Medical/Dental Instruments
- Sector
- BBCP Consumer Discretionary
- DCTH Health Care
- Exchange
- BBCP Nasdaq
- DCTH Nasdaq
- Market Cap
- BBCP 370.5M
- DCTH 379.5M
- IPO Year
- BBCP 2017
- DCTH N/A
- Fundamental
- Price
- BBCP $7.25
- DCTH $11.80
- Analyst Decision
- BBCP Buy
- DCTH Strong Buy
- Analyst Count
- BBCP 4
- DCTH 4
- Target Price
- BBCP $7.67
- DCTH $21.50
- AVG Volume (30 Days)
- BBCP 87.7K
- DCTH 389.0K
- Earning Date
- BBCP 01-09-2025
- DCTH 11-08-2024
- Dividend Yield
- BBCP N/A
- DCTH N/A
- EPS Growth
- BBCP N/A
- DCTH N/A
- EPS
- BBCP 0.26
- DCTH N/A
- Revenue
- BBCP $434,594,000.00
- DCTH $22,644,000.00
- Revenue This Year
- BBCP N/A
- DCTH $1,605.13
- Revenue Next Year
- BBCP N/A
- DCTH $111.67
- P/E Ratio
- BBCP $28.25
- DCTH N/A
- Revenue Growth
- BBCP N/A
- DCTH 945.91
- 52 Week Low
- BBCP $5.05
- DCTH $3.10
- 52 Week High
- BBCP $8.48
- DCTH $12.88
- Technical
- Relative Strength Index (RSI)
- BBCP 71.44
- DCTH 58.11
- Support Level
- BBCP $7.05
- DCTH $11.48
- Resistance Level
- BBCP $7.44
- DCTH $12.10
- Average True Range (ATR)
- BBCP 0.27
- DCTH 0.70
- MACD
- BBCP 0.05
- DCTH 0.07
- Stochastic Oscillator
- BBCP 87.66
- DCTH 71.39
About BBCP Concrete Pumping Holdings Inc.
Concrete Pumping Holdings Inc is a provider of concrete pumping services and concrete waste management services in the fragmented United States and United Kingdom markets. Its large fleet of specialized pumping equipment and trained operators position it to deliver concrete placement solutions. The company's operating segment includes U.S. Concrete Pumping; U.K. Operations; U.S. Concrete Waste Management Services and Corporate. It generates maximum revenue from the U.S. Concrete Pumping segment. Geographically, it generates majority of the revenue from its business in United States.
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.